Schaeffer's Top Stock Picks for '25

Moderna Stock Falls on Vaccine Revenue Concerns

Short interest is on the rise

Deputy Editor
Jan 29, 2025 at 9:00 AM
facebook X logo linkedin


Shares of Moderna Inc. (NASDAQ: MRNA) are down 3.2% in premarket trading after a bear note from Goldman Sachs. The firm lowered its rating on MRNA to "neutral" from "buy," and nearly halved its price target from $99 to $51, citing ongoing vaccine revenue challenges.

If these pre-market losses hold, Moderna stock could erase part of its 8.1% year-to-date lead and deepen its 57.1% year-over-year loss. The equity may also slip below a critical technical level -- its 20-day moving average -- which could pressure it toward its Jan. 13, nearly five-year low of $31.94.

Bearish sentiment is growing, as short interest in MRNA has surged 13.6% over the past two weeks. Currently, 43.01 million shares are sold short, making up 12.4% of the stock's total float.

It's worth noting the security has a history of exceeding volatility expectations, as evidenced by its elevated Schaeffer's Volatility Scorecard (SVS) rating of 99 out of 100. This makes now a good time to weigh in on the equity's next more with options.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?